JP5524177B2 - ほてりのためのステロイド治療 - Google Patents

ほてりのためのステロイド治療 Download PDF

Info

Publication number
JP5524177B2
JP5524177B2 JP2011504180A JP2011504180A JP5524177B2 JP 5524177 B2 JP5524177 B2 JP 5524177B2 JP 2011504180 A JP2011504180 A JP 2011504180A JP 2011504180 A JP2011504180 A JP 2011504180A JP 5524177 B2 JP5524177 B2 JP 5524177B2
Authority
JP
Japan
Prior art keywords
hot flashes
epoxy
steroid
hydroxyestradi
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2011504180A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011518136A (ja
JP2011518136A5 (cg-RX-API-DMAC7.html
Inventor
ルイス モンティ
Original Assignee
フェリン ファーマシューティカルズ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フェリン ファーマシューティカルズ インコーポレイテッド filed Critical フェリン ファーマシューティカルズ インコーポレイテッド
Publication of JP2011518136A publication Critical patent/JP2011518136A/ja
Publication of JP2011518136A5 publication Critical patent/JP2011518136A5/ja
Application granted granted Critical
Publication of JP5524177B2 publication Critical patent/JP5524177B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
JP2011504180A 2008-04-09 2009-04-09 ほてりのためのステロイド治療 Active JP5524177B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12362208P 2008-04-09 2008-04-09
US61/123,622 2008-04-09
PCT/US2009/040102 WO2009126825A1 (en) 2008-04-09 2009-04-09 Steroid treatment for hot flashes

Publications (3)

Publication Number Publication Date
JP2011518136A JP2011518136A (ja) 2011-06-23
JP2011518136A5 JP2011518136A5 (cg-RX-API-DMAC7.html) 2012-05-31
JP5524177B2 true JP5524177B2 (ja) 2014-06-18

Family

ID=41162250

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011504180A Active JP5524177B2 (ja) 2008-04-09 2009-04-09 ほてりのためのステロイド治療

Country Status (10)

Country Link
US (2) US20090258040A1 (cg-RX-API-DMAC7.html)
EP (1) EP2278880B1 (cg-RX-API-DMAC7.html)
JP (1) JP5524177B2 (cg-RX-API-DMAC7.html)
KR (1) KR101602802B1 (cg-RX-API-DMAC7.html)
CN (1) CN102056484B (cg-RX-API-DMAC7.html)
AU (1) AU2009234159B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0910637A2 (cg-RX-API-DMAC7.html)
DK (1) DK2278880T3 (cg-RX-API-DMAC7.html)
MX (1) MX2010011063A (cg-RX-API-DMAC7.html)
WO (1) WO2009126825A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3068590A1 (en) 2017-07-06 2019-01-10 Dignity Health Novel treatment for hot flushes
KR20210151836A (ko) 2019-04-15 2021-12-14 페린 파마슈티칼즈, 인코포레이티드 편두통의 치료
WO2024254005A1 (en) * 2023-06-04 2024-12-12 Vistagen Therapeutics, Inc. 1,3,5(10),16-estratetraen-3-yl acetate for use in improving psychomotor or cognitive performance
US20250312356A1 (en) * 2024-04-08 2025-10-09 Vistagen Therapeutics, Inc. Treatment of dysmenorrhea

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1158966B (de) * 1961-04-29 1963-12-12 Schering Ag Verfahren zur Herstellung von 6-Chlor-1, 2ª‡-methylen-í¸-17ª‡-hydroxyprogesteronestern
US6140316A (en) * 1991-01-07 2000-10-31 Pherin Corporation Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions
US5303703A (en) * 1991-10-03 1994-04-19 Pherin Corporation Combined neuroepithelial sample delivery electrode device and methods of using same
US5563131A (en) * 1994-08-04 1996-10-08 Pherin Corporation Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US6066627A (en) * 1994-08-04 2000-05-23 Pherin Corporation Steroids as neurochemical initiators of change in human blood levels of LH
US5994333A (en) * 1994-08-04 1999-11-30 Pherin Corporation Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US6057439A (en) 1994-08-04 2000-05-02 Pherin Corporation Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
US5792757A (en) * 1994-08-04 1998-08-11 Pherin Pharmaceuticals 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
US6117860A (en) * 1994-08-04 2000-09-12 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia
US6331534B1 (en) * 1994-08-04 2001-12-18 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to alleviate pain
DE69736833T2 (de) * 1996-07-23 2007-05-24 Pherin Pharmaceuticals, Inc., Menlo Park Steroide als neurochemische stimulatoren des nasenraumes zur linderung der prämenstrualen symptome
US6165504A (en) * 1998-09-23 2000-12-26 Barr Laboratories, Inc. Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
US6613758B1 (en) 1999-04-02 2003-09-02 Barr Laboratories, Inc. Method for treating osteoporosis in castrated prostatic cancer patients
WO2000059920A2 (en) * 1999-04-06 2000-10-12 Akzo Nobel N.V. Orally active 7.alpha.-alkyl androgens
US20030045514A1 (en) * 2001-05-03 2003-03-06 Louis Monti 17-Methyleneandrostan-3alpha-ol analogs as CRH inhibitors
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
RS20080200A (sr) * 2005-11-14 2009-07-15 Rinat Neuroscience Corp., Antagonistička antitela usmerena protiv kalcitonina, peptida povezanog sa genom, i postupak njihovog korišćenja
US20080293683A1 (en) 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy

Also Published As

Publication number Publication date
CN102056484B (zh) 2014-10-29
EP2278880A4 (en) 2011-08-10
BRPI0910637A2 (pt) 2015-07-28
KR20110014147A (ko) 2011-02-10
HK1157142A1 (en) 2012-06-29
WO2009126825A1 (en) 2009-10-15
US8431559B2 (en) 2013-04-30
DK2278880T3 (da) 2012-11-12
JP2011518136A (ja) 2011-06-23
US20090258040A1 (en) 2009-10-15
EP2278880A1 (en) 2011-02-02
KR101602802B1 (ko) 2016-03-11
US20120108558A1 (en) 2012-05-03
EP2278880B1 (en) 2012-10-10
AU2009234159A1 (en) 2009-10-15
MX2010011063A (es) 2010-11-22
AU2009234159B2 (en) 2013-12-19
CN102056484A (zh) 2011-05-11

Similar Documents

Publication Publication Date Title
JP6012048B2 (ja) アロマターゼ阻害剤およびゲスターゲンを放出する、子宮内膜症を処置するための非経口用剤形
Kupperman et al. Contemporary therapy of the menopausal syndrome
JPH09503774A (ja) 閉経直前及び閉経後の女性に対するホルモン置換療法用の黄体ホルモン拮抗物質及び部分的アゴニスト作用を有する抗エストロゲンの組合わせ
US20060254597A1 (en) Method of treatment of atrophic vaginitis by topical clitoral menthol or a related cooling compound
US20060106004A1 (en) Unique methods and formulations of bio-identical sex steroids for the treatment of pathophysiologic aberrations of menopause
JPH01502265A (ja) 避妊薬用としての性ステロイド放出と組合わされた黄体形成ホルモン放出ホルモン組成物の連続放出
Lauritzen Clinical use of oestrogens and progestogens
JP5524177B2 (ja) ほてりのためのステロイド治療
JP4450435B2 (ja) Ｐｍｓおよび不安の症状を緩和する、ｖｎｏにおける神経化学刺激物質としてのステロイド
JP6283689B2 (ja) うつ病性障害の処置のためのプレグナ‐４‐エン‐２０‐イン‐３‐オンの使用
HK1157142B (en) Steroid treatment for hot flashes
AU2020259269B2 (en) Treatment of migraine
US20250312356A1 (en) Treatment of dysmenorrhea
KR101368003B1 (ko) 사회 공포증의 급성 치료법
HK40068177B (en) Treatment of migraine
HK40068177A (en) Treatment of migraine
Villella The role of androgens in perimenopausal women: what are the herbal options?
Husain et al. Ovulation Induction

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120409

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120409

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130902

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131202

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140303

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140402

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140409

R150 Certificate of patent or registration of utility model

Ref document number: 5524177

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250